Generic drugs approved by FDA (through May 2011): bromfenac ophthalmic solution 0.09%, sodium ferric gluconate complex in sucrose injection, nitrofurantoin oral suspension
Bromfenac ophthalmic solution 0.09% (twice-daily administration) (equiv to Xibrom Ophthalmic Solution, 0.09% (Twice-Daily Administration)
MYLAN
Sodium ferric gluconate complex in sucrose injection (Nulecit) in 5-mL glass ampules (equiv to Ferrlecit)
WATSON
Nitrofurantoin Oral Suspension in 25 mg/5 mL strength (equiv to Furadantin)
AMNEAL
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.